Clinical Trial Update: Neoadjuvant Radiochemotherapy Combined With QL1706 for Low Rectal Cancer [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 trial is evaluating neoadjuvant radiochemotherapy combined with QL1706 for low rectal cancer, with the study currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• QL1706

Snippet

Sponsor: Changhai Hospital | Conditions: Rectal Cancer | EARLY_Phase 1 | Status: NOT_YET_RECRUITING